Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Portage Ventures is a private venture capital investment firm focused on fintech rather than biotechnology or healthcare therapeutics. The organization backs seed- to Series C-stage companies across insurance, consumer and SMB finance, wealth and asset management, and fintech infrastructure. The name "Portag3 Ventures" appears to be an older or alternative branding associated with what is now commonly presented as Portage Ventures. Although some portfolio companies operate in healthcare services or health insurance-adjacent segments, the firm itself is an investor and not a life sciences, biotech, pharma, or healthcare operating company. For biotech analyst purposes, this entity should be classified as a fintech-focused VC rather than a drug developer, healthcare services company, CRO, or platform therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Portag3 Ventures.